The present disclosure is generally directed to antiviral compounds, and more specifically directed to compounds which inhibit the function of the NS3 protease (also referred to herein as “serine protease”) encoded by Hepatitis C virus (HCV), compositions comprising such compounds, and methods for inhibiting the function of the NS3 protease.
本公开涉及抗病毒化合物,更具体地涉及抑制丙型肝炎病毒(HCV)编码的
NS3蛋白酶(本文中也称为“
丝氨酸蛋白酶”)功能的化合物,包括这种化合物的组合物,以及抑制
蛋白酶功能的方法。